Alexandre Avraméas

1.1k total citations
23 papers, 652 citations indexed

About

Alexandre Avraméas is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alexandre Avraméas has authored 23 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alexandre Avraméas's work include Monoclonal and Polyclonal Antibodies Research (8 papers), T-cell and B-cell Immunology (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Alexandre Avraméas is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), T-cell and B-cell Immunology (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Alexandre Avraméas collaborates with scholars based in Switzerland, France and United States. Alexandre Avraméas's co-authors include Gérard Buttin, Thérèse Ternynck, An Sha Zhao, François Legay, Marie‐Anne Valentin, Faridabano Nato, Stratis Avraméas, Brigitte Autran, Patrice Debré and Annie Claude Roche and has published in prestigious journals such as Proceedings of the National Academy of Sciences, International Journal of Molecular Sciences and Journal of Hepatology.

In The Last Decade

Alexandre Avraméas

23 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexandre Avraméas Switzerland	13	251	249	144	114	93	23	652
Till A. Röhn Switzerland	14	549 2.2×	271 1.1×	85 0.6×	90 0.8×	39 0.4×	20	860
Ido Lubin Israel	19	481 1.9×	220 0.9×	106 0.7×	363 3.2×	107 1.2×	43	1.1k
Yasuhiro Nagai Japan	18	467 1.9×	329 1.3×	53 0.4×	113 1.0×	81 0.9×	45	986
Thomas M. Yankee United States	16	486 1.9×	233 0.9×	103 0.7×	48 0.4×	41 0.4×	35	897
JE de Vries United States	14	687 2.7×	168 0.7×	95 0.7×	75 0.7×	51 0.5×	25	1.1k
Erik J. Novak United States	10	725 2.9×	192 0.8×	95 0.7×	111 1.0×	208 2.2×	11	1.0k
Sébastien Calbo France	16	570 2.3×	173 0.7×	66 0.5×	69 0.6×	58 0.6×	32	926
Christophe Lallemand France	14	365 1.5×	237 1.0×	140 1.0×	140 1.2×	59 0.6×	24	728
S K Narula United States	14	671 2.7×	215 0.9×	68 0.5×	107 0.9×	113 1.2×	24	983
Satoru Tsuruta Japan	17	138 0.5×	140 0.6×	45 0.3×	75 0.7×	78 0.8×	56	638

Countries citing papers authored by Alexandre Avraméas

Since Specialization

Citations

This map shows the geographic impact of Alexandre Avraméas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Avraméas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Avraméas more than expected).

Fields of papers citing papers by Alexandre Avraméas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Avraméas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Avraméas. The network helps show where Alexandre Avraméas may publish in the future.

Co-authorship network of co-authors of Alexandre Avraméas

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Avraméas. A scholar is included among the top collaborators of Alexandre Avraméas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Avraméas. Alexandre Avraméas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dörner, Thomas, Simon Bowman, Robert I. Fox, et al.. (2024). Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study. Arthritis & Rheumatology. 77(5). 560–570. 3 indexed citations

Dörner, Thomas, Alexandre Avraméas, Ulrich Sommer, et al.. (2024). POS0540 REDUCTION OF B CELL SUBSETS, AUTOANTIBODIES AND DISEASE-RELEVANT PATHWAYS IN IANALUMAB TREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: FINDINGS FROM A PHASE 2 CLINICAL TRIAL. Annals of the Rheumatic Diseases. 83. 956–957. 1 indexed citations

Dörner, Thomas, Martin Kaul, Antónia Szántó, et al.. (2023). Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren’s syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial. Annals of the Rheumatic Diseases. 83(3). 360–371. 22 indexed citations

Michaud, Philippe, et al.. (2023). Central and Peripheral Inflammation in Mild Cognitive Impairment in the Context of Alzheimer’s Disease. International Journal of Molecular Sciences. 24(13). 10523–10523. 11 indexed citations

Posch, Maximilian, Roland Feifel, Tobias Junt, et al.. (2023). First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults. European Journal of Drug Metabolism and Pharmacokinetics. 48(5). 553–566. 10 indexed citations

Penno, Carlos A., Andreas Hofmann, Dirk J. Schaefer, et al.. (2020). Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4. Journal of Investigative Dermatology. 140(12). 2421–2432.e10. 40 indexed citations

Espié, Pascal, Yanling He, Phillip J. Koo, et al.. (2019). First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody. American Journal of Transplantation. 20(2). 463–473. 68 indexed citations

Budde, Petra, Rémi Kazma, Patrick D. Maguire, et al.. (2017). SAT0301 Serum autoantibody profiling of primary sjÖgren's syndrome patients reveals novel biomarkers associated with the disease, disease activity, and clinical response to vay736. Annals of the Rheumatic Diseases. 76. 886–886. 1 indexed citations

Valentin, Marie‐Anne, et al.. (2011). Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies. Journal of Pharmaceutical and Biomedical Analysis. 55(5). 869–877. 105 indexed citations

10.

Doucet, Julie & Alexandre Avraméas. (2010). A novel method for quantitative measurement of a therapeutic monoclonal antibody in the presence of its target protein using enzymatic digestion. Journal of Pharmaceutical and Biomedical Analysis. 52(4). 565–570. 10 indexed citations

11.

Doucet, Julie, et al.. (2009). Reduction of matrix interferences by the combination of chaotropic salt and DMSO in a broadly applicable target-based ELISA for pharmacokinetic studies of therapeutic monoclonal antibodies. Journal of Pharmaceutical and Biomedical Analysis. 50(5). 924–931. 6 indexed citations

12.

Avraméas, Alexandre, et al.. (2001). DNA and Heparin Alter the Internalization Process of Anti-DNA Monoclonal Antibodies According to Patterns Typical of Both the Charged Molecule and the Antibody. Journal of Autoimmunity. 16(4). 383–391. 12 indexed citations

13.

Ternynck, Thérèse, Alexandre Avraméas, Josiane Ragimbeau, Gérard Buttin, & Stratis Avraméas. (1998). Immunochemical, Structural and Translocating Properties of Anti-DNA Antibodies from (NZB×NZW)F1 Mice. Journal of Autoimmunity. 11(5). 511–521. 24 indexed citations

14.

Avraméas, Alexandre, Thérèse Ternynck, Faridabano Nato, Gérard Buttin, & Stratis Avraméas. (1998). Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. Proceedings of the National Academy of Sciences. 95(10). 5601–5606. 64 indexed citations

15.

Avraméas, Alexandre, et al.. (1998). Efficient Gene Delivery by a Peptide Derived from a Monoclonal anti-DNA Antibody. Bioconjugate Chemistry. 10(1). 87–93. 18 indexed citations

16.

Sibille, Pierre, Thérèse Ternynck, Faridabano Nato, et al.. (1997). Mimotopes of polyreactive anti‐DNA antibodies identified using phage‐display peptide libraries. European Journal of Immunology. 27(5). 1221–1228. 44 indexed citations

17.

Avraméas, Alexandre, Dorian McIlroy, Anne Hosmalin, et al.. (1996). Expression of a mannose/fucose membrane lectin on human dendritic cells. European Journal of Immunology. 26(2). 394–400. 108 indexed citations

18.

Sibille, Pierre, Alexandre Avraméas, A. Moraillon, et al.. (1995). Comparison of serological tests for the diagnosis of feline immunodeficiency virus infection of cats. Veterinary Microbiology. 45(2-3). 259–267. 16 indexed citations

19.

Avraméas, Alexandre, A. Donny Strosberg, A. Moraillon, P. Sonigo, & Gianfranco Pancino. (1993). Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins. Research in Virology. 144(3). 209–218. 34 indexed citations

20.

Avraméas, Alexandre, Jean‐Gérard Guillet, Lotfi Chouchane, et al.. (1992). Localisation of three epitopes of the ENV protein of feline immunodeficiency virus. Molecular Immunology. 29(5). 565–572. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact